Warning: include(/mnt/ebs/scidaily/dfp/.inc.php): failed to open stream: No such file or directory in /mnt/ebs/scidaily/public_html/video.php on line 720 Warning: include(): Failed opening '/mnt/ebs/scidaily/dfp/.inc.php' for inclusion (include_path='.:/usr/share/php:/usr/share/pear') in /mnt/ebs/scidaily/public_html/video.php on line 720 Non-White Patients Suffer From Lack of Marrow, Stem Cell Donors -- ScienceDaily

Science Videos

from AP, Reuters, AFP, and other news services

Non-White Patients Suffer From Lack of Marrow, Stem Cell Donors

Date:
May 27, 2013
Source:
CBC / Powered by NewsLook.com
Summary:
There are concerns a dramatic shortage of stem cell and bone marrow donors from non-Caucasian ethnic groups is putting lives in jeopardy.


Related Videos

last updated on 2014-04-23 at 8:38 am EDT

The Pros and Cons of Banking Your Baby’s Stem Cells

The Pros and Cons of Banking Your Baby’s Stem Cells

Ivanhoe (Jan. 15, 2014) — Umbilical cord stem cell banking: it can be expensive and controversial, but for one family the decision to pursue cord stem cell banking saved their baby’s life. Check out the pros and cons of banking your baby’s stem cells.
Powered by NewsLook.com
Autism and Cord Blood Stem Cells: FDA Gives Green Lite for Groundbreaking Clinical Trial

Autism and Cord Blood Stem Cells: FDA Gives Green Lite for Groundbreaking Clinical Trial

MultiVu (Aug. 21, 2012) — Sutter Neuroscience Institute, a recognized Center of Excellence, and CBR (Cord Blood Registry), the world's largest stem cell bank, are launching the first FDA- approved clinical trial to assess the use of a child's own cord blood stem cells to treat select patients with autism. This first-of-its-kind placebo controlled study will evaluate the ability of an infusion of cord blood stem cells to help improve language and behavior. The study is in conjunction with the Sutter Institute for Medical Research.
Powered by NewsLook.com
Fast Track: Drugs for Fatty Liver Disease, Non-Small Cell Lung Adenocarcinoma

Fast Track: Drugs for Fatty Liver Disease, Non-Small Cell Lung Adenocarcinoma

Ivanhoe (Oct. 17, 2013) — Researchers are on the fast track to develop a drug that could reverse fibrosis and cirrhosis in the kidneys, lungs and liver of patients who have NASH (non-alcoholic steatohepatitis), or fatty liver disease. Another potential breakthrough receiving fast-track status: a treatment to improve overall survival in patients with metastatic non-small cell lung adenocarcinoma.
Powered by NewsLook.com
Older Stem Cell Donors Turned Away

Older Stem Cell Donors Turned Away

CBC (Oct. 1, 2012) — Héma-Québec has quietly lowered the maximum age of those who can sign up to be stem-cell donors from 50 to 35, raising concerns that it will be harder for some people to find a match.
Powered by NewsLook.com

Related Stories


Share This



Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins